Companies:
49,824
Total Market Cap:
139401351959620.41
Global Rank
#27357
Country Rank
#373
Market Cap
68.94 M
Price
13.19
Change (%)
0.89%
Volume
0
HAEMATO AG's latest marketcap:
68.94 M
As of 07/05/2025, HAEMATO AG's market capitalization has reached $68.94 M. According to our data, HAEMATO AG is the 27357th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 68.94 M |
| Revenue (ttm) | 307.09 M |
| Net Income (ttm) | 11.32 M |
| Shares Out | 5.23 M |
| EPS (ttm) | 2.21 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 07/16/2025 |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 07/05/2025
HAEMATO AG's yearly market capitalization.
HAEMATO AG has seen its market value drop from €119.19 M to €68.94 M since 2021, representing a total decrease of 42.16% and an annual compound decline rate (CAGR) of 14.12%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €68.94 M | -9.68% | 27357 |
| 12/30/2024 | €64.82 M | -40.95% | 25938 |
| 06/28/2022 | €109.78 M | -7.89% | 21241 |
| 11/30/2021 | €119.19 M | 21179 |
Company Profile
About HAEMATO AG
HAEMATO AG, along with its subsidiaries, is a key player in the German pharmaceutical sector. The company focuses on the development, acquisition, licensing, and distribution of a diverse range of healthcare products.
Business Segments
- Specialty Pharma: Provides prescription drugs and OTC products, specializing in HIV/AIDS, neurology, oncology, and rheumatology.
- Lifestyle & Aesthetics: Offers special cosmetics and dietary supplements under brands like M1 SELECT.
Product Portfolio
- Pharmaceuticals for chronic and specialized treatments.
- Diagnostic tests under the HAEMATO brand.
- Third-party product distribution.
Customer Base
HAEMATO AG serves a wide network of clients, including:
- Clinics
- Pharmacies
- Wholesalers
- Medical test centers
Company Background
Founded in 1993, HAEMATO AG is headquartered in Schönefeld, Germany.
Frequently Asked Questions
-
What is HAEMATO AG's (HAM-HAEK) current market cap?As of 07/05/2025, HAEMATO AG (including the parent company, if applicable) has an estimated market capitalization of $68.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does HAEMATO AG (HAM-HAEK) rank globally by market cap?HAEMATO AG global market capitalization ranking is approximately 27357 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.